Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Accounts payable and accrued liabilities | 24 | 3 | 3 | 0 | 22 |
| Other Working Capital | -7 | -14 | 3 | 49 | 8 |
| Other Operating Activity | -17 | -10 | -7 | -49 | -31 |
| Operating Cash Flow | $0 | $-21 | $0 | $0 | $-1 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 20 | N/A | N/A |
| Financing Cash Flow | $0 | $0 | $20 | $0 | $0 |
| Beginning Cash Position | 0 | 22 | 2 | 2 | 3 |
| End Cash Position | 0 | 0 | 22 | 2 | 2 |
| Net Cash Flow | $0 | $-21 | $20 | $0 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | -21 | 0 | 0 | -1 |
| Free Cash Flow | 0 | -21 | 0 | 0 | -1 |